Sign In
Buy VXRT
$0.519
-0.0111 (-2.09%)
At Close: Jun 23, 2026
Top Ranked Momentum Stocks to Buy for March 25th
11:08am, Wednesday, 25'th Mar 2020
Top Ranked Momentum Stocks to Buy for March 25th
Coronavirus Drug Development Race to Boost These 4 Stocks
10:54am, Wednesday, 25'th Mar 2020
Fast-track approval for coronavirus drug trials is encouraging drug developers. Here are four stocks that can make the most of this phase.
Here're the 5 Big Winners from the Coronavirus Pandemic
08:05am, Tuesday, 24'th Mar 2020
Even though several companies have suffered badly from the COVID-19 outbreak, here're five that stand to benefit from the pandemic.
Emergent (EBS) to Help Vaxart Develop Coronavirus Vaccine
11:55am, Thursday, 19'th Mar 2020
Emergent BioSolutions (EBS) teams up with Vaxart to support development of the latter's oral vaccine candidate for treating coronavirus disease.
Top Ranked Momentum Stocks to Buy for March 19th
10:25am, Thursday, 19'th Mar 2020
Top Ranked Momentum Stocks to Buy for March 19th
Vaxart, Emergent Biosolutions Partner On Coronavirus Vaccine Development
11:48am, Wednesday, 18'th Mar 2020
Vaxart Inc (NASDAQ: VXRT) shares were advancing Wednesday following an update from the company on its COVID-19 vaccine program.
Vaxart: Emergent to manufacture Vaxart's experimental COVID-19 vaccine
06:54am, Wednesday, 18'th Mar 2020
Shares of Vaxart Inc. VXRT, +63.56% jumped 48% in premarket trading on Wednesday after the company said it had signed a deal with Emergent BioSolutions Inc.
Oral Vaccines based on Proprietary VAAST™ Platform Offer Potential Key Advantages in Global Quest to Develop Coronavirus Vaccine Oral Vaccines based on Proprietary VAAST™ Platform Offer Potential
GAITHERSBURG, Md., March 18, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered into an agreement with Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage b
Top Ranked Momentum Stocks to Buy for March 17th
09:21am, Tuesday, 17'th Mar 2020
Top Ranked Momentum Stocks to Buy for March 17th
8 Biotechs With Coronavirus Vaccines In Development
10:42am, Monday, 16'th Mar 2020
The outbreak of COVID-19 caused by the new coronavirus SARS-CoV-2 is roiling the global economy.
How Close Are Biotechs To Bringing A COVID-19 Treatment To Market?
05:24pm, Tuesday, 10'th Mar 2020
The COVID-19 virus has sent the market and the global economy into a tailspin. The Organisation for Economic Co-operation and Development slashed its global growth forecast for 2020 Monday by 0.5 poi
5 Reasons to Buy These Small-Cap Stocks Now
07:49am, Thursday, 05'th Mar 2020
After a painful stretch, small-cap U.S. stocks should rebound on a few tailwinds.
3 Correction-Defying Bets to Buy as Markets Brave Coronavirus
09:16am, Wednesday, 04'th Mar 2020
Global markets lost $6 trillion in the week ended Feb 29 as coronavirus triggered sharp selloff. Here's how to play the dip.
Trump Asks Pharma Firms to Step Up Coronavirus Vaccine Work
09:34am, Tuesday, 03'rd Mar 2020
President Donald Trump asks pharmaceutical companies working on making vaccines or treatments for coronavirus to accelerate development.
